To Evaluate the Clinical Efficacy of Probiotics in Patients with the Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions
Breast Cancer
Interventions
DIETARY_SUPPLEMENT

Probiotic

Three-strain probiotic supplement includes Lactobacillus reuteri GMNL-89 (alive), Lactobacillus plantarum GMNL-141 (alive) and Lactobacillus paracasei GMNL-133 (alive).

OTHER

Placebo

Same additives to Probiotic group but replace probiotics with corn starch and Maltodextrin.

Trial Locations (1)

Unknown

RECRUITING

Mackay Memorial Hospital, Taipei

All Listed Sponsors
collaborator

Mackay Memorial Hospital

OTHER

lead

GenMont Biotech Incorporation

INDUSTRY